Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19.
Journal Information
Full Title: J Clin Virol
Abbreviation: J Clin Virol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of Competing Interests Ingvild Birschmann received speaker's honoraria from Aspen Germany GmbH, Bristol-Myers Squibb/Pfizer, Siemens Healthcare and CSL Behring and reimbursement for congress traveling and accommodation from aspen and performed contract research for Siemens Healthcare. Ingvild Birschmann is a member of the advisory board of LFB biomedicaments, Siemens Healthcare, CSL Behring and Alexion Pharma Germany GmbH. Tobias Flieder, Bastian Fischer, Katharina von Bargen, Andreas Peter and Cornelius Knabbe have nothing to disclose."
Funding Disclosure
Evidence found in paper:
"Funding Not applicable."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025